Related Experiment Videos
[Frontolateral laryngectomy. Our experience in La Rioja].
G Calzada Uriondo1, A Sánchez del Hoyo, J A Preciado López
1Servicio de ORL, Complejo Hospitalario San Millán-San Pedro, Autonomía de La Rioja, 3, 26004 Logroño, La Rioja.
Acta Otorrinolaringologica Espanola
|March 29, 2001
Summary
Frontolateral laryngectomy is effective for T1b glottic tumors, with high survival rates. Most patients treated for glottic cancer remained recurrence-free for five years post-surgery.
Area of Science:
- Otolaryngology
- Oncology
Context:
- Glottic tumors represent a subset of laryngeal cancers.
- Early-stage glottic tumors (T1b) require effective treatment strategies.
- Frontolateral laryngectomy is a surgical option for laryngeal malignancies.
Purpose:
- To evaluate the outcomes of frontolateral laryngectomy in T1b glottic tumor patients.
- To analyze recurrence and survival rates following this surgical approach.
Summary:
- A retrospective study analyzed 16 patients with T1b glottic tumors treated via frontolateral laryngectomy between 1989-1998.
- Data on demographics, toxic habits, diagnosis, surgery, recurrence, and survival were assessed.
- Epidermoid carcinoma was the predominant diagnosis (96.75%).
- Survival analysis revealed 87.5% of patients were recurrence-free at five years, with only 6.25% experiencing local recurrence.
Impact:
- Demonstrates favorable long-term outcomes for frontolateral laryngectomy in early-stage glottic cancer.
- Provides evidence supporting surgical management for T1b glottic tumors.
- Contributes to understanding recurrence patterns and survival in laryngeal cancer patients.